• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶剂/去污剂处理血浆传播戊型肝炎病毒的风险。

Risk for Hepatitis E Virus Transmission by Solvent/Detergent-Treated Plasma.

出版信息

Emerg Infect Dis. 2020 Dec;26(12):2881-2886. doi: 10.3201/eid2612.191482.

DOI:10.3201/eid2612.191482
PMID:33219652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7706953/
Abstract

Hepatitis E has emerged as a major transfusion-transmitted infectious risk. Two recipients of plasma from 2 lots (A and B) of pooled solvent/detergent-treated plasma were found to be infected by hepatitis E virus (HEV) that was determined to have been transmitted by the solvent/detergent-treated plasma. HEV RNA viral loads were 433 IU in lot A and 55 IU in lot B. Retrospective studies found that 100% (13/13) of evaluable lot A recipients versus 18% (3/17) of evaluable lot B recipients had been infected by HEV (p<0.001), albeit not necessarily at time of transfusion. Among evaluable recipients, 86% with a transfused HEV RNA load >50,000 IU were infected, most likely by the HEV-containing solvent/detergent-treated plasma, versus only 7% with a transfused HEV RNA load <50,000 IU (p<0.001). Overall, solvent/detergent-treated plasma might harbor HEV. Such an occurrence might result in a dose-dependent risk for transfusion-transmitted hepatitis E.

摘要

戊型肝炎已成为主要的输血传播感染风险。从 2 批(A 和 B)经溶剂/去污剂处理的混合血浆中发现的 2 名受血者感染了戊型肝炎病毒(HEV),该病毒确定是由溶剂/去污剂处理的血浆传播的。A 批的 HEV RNA 病毒载量为 433 IU,B 批为 55 IU。回顾性研究发现,100%(13/13)可评估的 A 批受血者和 18%(3/17)可评估的 B 批受血者被 HEV 感染(p<0.001),尽管不一定是在输血时。在可评估的受血者中,86%的输注 HEV RNA 载量>50000 IU 的受血者被感染,最有可能是通过含有 HEV 的溶剂/去污剂处理的血浆,而输注 HEV RNA 载量<50000 IU 的受血者只有 7%(p<0.001)。总的来说,溶剂/去污剂处理的血浆可能携带 HEV。这种情况可能导致输血传播性戊型肝炎的剂量依赖性风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4128/7706953/f9ba0d1481d2/19-1482-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4128/7706953/f9ba0d1481d2/19-1482-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4128/7706953/f9ba0d1481d2/19-1482-F.jpg

相似文献

1
Risk for Hepatitis E Virus Transmission by Solvent/Detergent-Treated Plasma.溶剂/去污剂处理血浆传播戊型肝炎病毒的风险。
Emerg Infect Dis. 2020 Dec;26(12):2881-2886. doi: 10.3201/eid2612.191482.
2
[Hepatitis E virus: Blood transfusion implications].[戊型肝炎病毒:输血的影响]
Transfus Clin Biol. 2014 Nov;21(4-5):173-7. doi: 10.1016/j.tracli.2014.07.007. Epub 2014 Sep 27.
3
Hepatitis E virus in blood components: a prevalence and transmission study in southeast England.血液制品中的戊型肝炎病毒:英格兰东南部的流行率和传播研究。
Lancet. 2014 Nov 15;384(9956):1766-73. doi: 10.1016/S0140-6736(14)61034-5. Epub 2014 Jul 28.
4
HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients.抗 -HEV 阳性血液捐赠对免疫抑制受者构成相关感染风险。
J Hepatol. 2018 Jul;69(1):36-42. doi: 10.1016/j.jhep.2018.02.031. Epub 2018 Mar 15.
5
Risk of transfusion-transmitted hepatitis E virus infection from pool-tested platelets and plasma.经池检测的血小板和血浆传播输血传播性戊型肝炎病毒感染的风险。
J Hepatol. 2022 Jan;76(1):46-52. doi: 10.1016/j.jhep.2021.08.018. Epub 2021 Aug 27.
6
Transfusion-transmitted hepatitis E in Germany, 2013.德国 2013 年经输血传播的戊型肝炎。
Euro Surveill. 2014 May 29;19(21):20812. doi: 10.2807/1560-7917.es2014.19.21.20812.
7
Transfusion-Transmitted Hepatitis E Virus Infection in France.法国经输血传播的戊型肝炎病毒感染。
Transfus Med Rev. 2019 Jul;33(3):146-153. doi: 10.1016/j.tmrv.2019.06.001. Epub 2019 Jun 20.
8
Hepatitis E virus RNA in Australian blood donors: prevalence and risk assessment.澳大利亚献血者中的戊型肝炎病毒RNA:流行率与风险评估
Vox Sang. 2017 Oct;112(7):614-621. doi: 10.1111/vox.12559. Epub 2017 Aug 18.
9
Serological and molecular evidence of a plausible transmission of hepatitis E virus through pooled plasma.血清学和分子证据表明,混合血浆可能传播戊型肝炎病毒。
Vox Sang. 2014 Oct;107(3):213-9. doi: 10.1111/vox.12156. Epub 2014 May 15.
10
[Assessment of a transfusion emergent risk: the case of HEV].[输血紧急风险评估:戊型肝炎案例]
Transfus Clin Biol. 2014 Nov;21(4-5):162-6. doi: 10.1016/j.tracli.2014.07.004. Epub 2014 Sep 27.

引用本文的文献

1
Thermal Inactivation of Hepatitis E Virus: A Narrative Review.戊型肝炎病毒的热灭活:一篇叙述性综述。
Viruses. 2025 May 14;17(5):702. doi: 10.3390/v17050702.
2
HEV in Blood Donors in Switzerland: The Route to Safe Blood Products.瑞士献血者中的戊型肝炎病毒:通往安全血液制品之路。
Pathogens. 2024 Oct 18;13(10):911. doi: 10.3390/pathogens13100911.
3
Assessment of Hepatitis E virus transmission risks: a comprehensive review of cases among blood transfusion recipients and blood donors.戊型肝炎病毒传播风险评估:对输血受者和献血者中病例的全面综述
Infect Ecol Epidemiol. 2024 Oct 15;14(1):2406834. doi: 10.1080/20008686.2024.2406834. eCollection 2024.
4
Prevalence of Acute Hepatitis E Virus Infections in Swiss Blood Donors 2018-2020.2018-2020 年瑞士献血者中急性戊型肝炎病毒感染的流行情况。
Viruses. 2024 May 8;16(5):744. doi: 10.3390/v16050744.
5
Porcine-derived pancreatic enzyme replacement therapy may be linked to chronic hepatitis E virus infection in cystic fibrosis lung transplant recipients.猪源性胰腺酶替代治疗可能与囊性纤维化肺移植受者的慢性戊型肝炎病毒感染有关。
Gut. 2024 Sep 9;73(10):1702-1711. doi: 10.1136/gutjnl-2023-330602.
6
Transmission of Hepatitis E Virus.戊型肝炎病毒传播。
Adv Exp Med Biol. 2023;1417:73-92. doi: 10.1007/978-981-99-1304-6_6.
7
Transfusion-transmitted hepatitis E: What we know so far?经输血传播的戊型肝炎:目前我们了解多少?
World J Gastroenterol. 2022 Jan 7;28(1):47-75. doi: 10.3748/wjg.v28.i1.47.
8
Effect of Hepatitis E Virus RNA Universal Blood Donor Screening, Catalonia, Spain, 2017‒2020.2017-2020 年西班牙加泰罗尼亚实施戊型肝炎病毒 RNA 通用献血者筛查的效果。
Emerg Infect Dis. 2022 Jan;28(1):157-165. doi: 10.3201/eid2801.211466.

本文引用的文献

1
Transfusion-Transmitted Hepatitis E Virus Infection in France.法国经输血传播的戊型肝炎病毒感染。
Transfus Med Rev. 2019 Jul;33(3):146-153. doi: 10.1016/j.tmrv.2019.06.001. Epub 2019 Jun 20.
2
Transfusion-Transmitted Hepatitis E: NAT Screening of Blood Donations and Infectious Dose.输血传播的戊型肝炎:献血的核酸检测筛查与感染剂量
Front Med (Lausanne). 2018 Feb 1;5:5. doi: 10.3389/fmed.2018.00005. eCollection 2018.
3
Hepatitis E virus infection.戊型肝炎病毒感染。
Nat Rev Dis Primers. 2017 Nov 16;3:17086. doi: 10.1038/nrdp.2017.86.
4
Characterization of the lipid envelope of exosome encapsulated HEV particles protected from the immune response.对封装在细胞外囊泡中的戊型肝炎病毒颗粒脂质包膜的表征,该包膜可免受免疫反应影响。
Biochimie. 2017 Oct;141:70-79. doi: 10.1016/j.biochi.2017.05.003. Epub 2017 May 5.
5
Unique clinical courses of transfusion-transmitted hepatitis E in patients with immunosuppression.免疫抑制患者输血传播戊型肝炎的独特临床病程。
Transfusion. 2017 Feb;57(2):280-288. doi: 10.1111/trf.13994. Epub 2017 Jan 31.
6
Hepatitis E Virus Infection in Solid Organ Transplant Recipients, France.法国实体器官移植受者中的戊型肝炎病毒感染
Emerg Infect Dis. 2017 Feb;23(2):353-356. doi: 10.3201/eid2302.161094.
7
Comparison of hepatitis E virus nucleic acid test screening platforms and RNA prevalence in French blood donors.法国献血者中戊型肝炎病毒核酸检测筛查平台及RNA流行率的比较
Transfusion. 2017 Jan;57(1):223-224. doi: 10.1111/trf.13889.
8
A nationwide survey of hepatitis E viral infection in French blood donors.一项针对法国献血者中戊型肝炎病毒感染的全国性调查。
Hepatology. 2016 Apr;63(4):1145-54. doi: 10.1002/hep.28436. Epub 2016 Feb 26.
9
Naked Viruses That Aren't Always Naked: Quasi-Enveloped Agents of Acute Hepatitis.并非总是赤裸裸的病毒:急性肝炎的准包膜性病原体。
Annu Rev Virol. 2014 Nov;1(1):539-60. doi: 10.1146/annurev-virology-031413-085359. Epub 2014 Jul 3.
10
Hepatitis E virus infections in blood donors, France.法国献血者中的戊型肝炎病毒感染
Emerg Infect Dis. 2014 Nov;20(11):1914-7. doi: 10.3201/eid2011.140516.